| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Apr―18 |
A Review on Novel Coronavirus (COVID 19) Vaccines AstraZeneca, Pfizer, Moderna |
Kiran Dubey |
| 2 |
[GO] |
2024―Aug―20 |
Hemophagocytic Lymphohistiocytosis Triggered by COVID-19: A Case Report and Literature Review |
Yuexia Zhang |
| 3 |
[GO] |
2024―Aug―20 |
Centralized Medical Observation in the COVID-19 Response: A Retrospective Field Study |
Jian Jiang, Wenqing Rao, Xuwei Tang, Xiangju Hu, Shuting Wu |
| 4 |
[GO] |
2024―Jul―05 |
Psychosocial Impact of COVID-19 on Occupants in Nigeria |
Oluchi A Olofin |
| 5 |
[GO] |
2024―Jun―11 |
Insect Chemosensory Proteins against COVID-19 |
Jean-François Picimbon |
| 6 |
[GO] |
2024―May―20 |
The View Point of Covid-19: Update Information |
E Ghazizadeh, Zahra Naseri |
| 7 |
[GO] |
2024―Jan―22 |
Impact of COVID-19 Infection on Patients with Parkinson’s Disease: A Cross-Sectional Study |
Ya Bai, Xuedong Liu |
| 8 |
[GO] |
2023―Dec―06 |
Long COVID-19 |
Leonor Chacin Bonilla |
| 9 |
[GO] |
2023―Dec―06 |
Virtual Screening and Binding Mode Analysis of Selected FDA Approved Drugs Against PLpro Target: An Effort to Identify Therapeutics to Combat COVID-19 |
Mitra Ashouri |
| 10 |
[GO] |
2023―Aug―24 |
The Effects of COVID-19 on the Compliance of Dental Operators with Infection Control in Saudi Arabia: A Review |
Muhannad Q Alanazi |
| 11 |
[GO] |
2023―Jul―22 |
Repurposing of Some VEGFR-2 Inhibitors: In Silico Molecular Dynamics Simulation (at 200 ns), Docking Based on the SARS-CoV-2-Main-Protease Inhibitor N3 |
Khaled El Adl |
| 12 |
[GO] |
2023―Jun―26 |
Methodology for Predicting Time Processes using Neural Technologies on the example of the Spread of Covid-19 in the Russian Federation and Moscow |
Aduard Dadyan |
| 13 |
[GO] |
2023―Jun―26 |
Long Covid & Antidepressants |
Rafael Rivas Vazquez |
